دورية أكاديمية

SURVIVAL OF PATIENTS WITH METASTATIC CANCER FOR MORE THAN THREE YEARS AFTER STARTING CONTINUOUS INFUSION IL-2 THERAPY IN TRIALS OF THE NATIONAL BIOTHERAPY STUDY GROUP (NBSG)

التفاصيل البيبلوغرافية
العنوان: SURVIVAL OF PATIENTS WITH METASTATIC CANCER FOR MORE THAN THREE YEARS AFTER STARTING CONTINUOUS INFUSION IL-2 THERAPY IN TRIALS OF THE NATIONAL BIOTHERAPY STUDY GROUP (NBSG)
المؤلفون: Dillman, R. O., Oldham, R. K., Church, C., Sowell, M.
المصدر: Journal of Immunotherapy ; volume 18, issue 2, page 129 ; ISSN 1524-9557
بيانات النشر: Ovid Technologies (Wolters Kluwer Health)
سنة النشر: 1995
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1097/00002371-199508000-00017
الإتاحة: https://doi.org/10.1097/00002371-199508000-00017Test
https://journals.lww.com/00002371-199508000-00017Test
رقم الانضمام: edsbas.C6C43EA6
قاعدة البيانات: BASE